Should providers prescribe sacubitril/valsartan based on trial eligibility, approval indication, or guideline recommendations?
Authors: Ambrosy AP; Fudim M; Chioncel O
Eur J Heart Fail. 2019 11;21(11):1398-1401. Epub 2019-07-22.
Division of Research
2000 Broadway
Oakland, CA 94612
(510) 891-3400
Privacy Policy | Terms and Conditions
Follow us on these external social media sites that will open in a new browser window.
© 2023 Kaiser Permanente Division of Research